Featured Vendors(September) - 2024

IV therapy is gaining worldwide popularity as people turn to intravenous supplements for health and well-being. Traditionally confined to hospitals and infusion centers for medical needs, recent years have witnessed a surge in independent boutiques and community providers offering elective IV hydration and vitamin therapies. IV hydration therapy, in particular, addresses severe dehydration resulting from fever, excessive sweating, vomiting, or chronic illnesses. It effectively restores electrolyte balance, catering to those with conditions like diabetes or certain kidney ailments. Among the common IV treatments, saline solutions containing water and sodium chloride are prevalent, along with sugarbased solutions like glucose and dextrose.

According to research, the global Intravenous Therapy and Vein Access Market is projected to continue its growth, estimated to reach $37.5 billion by 2030, with a CAGR of 5.1 percent. This expansion is attributed to ongoing research and development activities in IV therapies and the increasing demand for at-home medication administration. A notable driving force behind this growth is intravenous ports’ use to deliver chemotherapy to cancer patients. Initiatives enhancing knowledge and awareness regarding the implantation, administration, and maintenance of chemo ports among cancer stakeholders and caregivers have further propelled this segment. Moreover, intravenous therapy is vital in delivering medications for various chronic conditions, including rheumatoid arthritis, Crohn’s disease, osteoporosis, systemic lupus, multiple sclerosis, psoriasis, and gout. With the rising incidence of these chronic diseases and an increasing number of surgeries worldwide, there is a growing demand for intravenous therapy and vein access devices. This expansion is facilitated by technological advancements and the growing adoption of implantable ports, making intravenous therapy a critical component of modern healthcare.

This edition of Medical Care Review brings to readers the key developments in the IV therapy space and how firms leverage the latest technologies to offer top-notch services. It features thought leadership articles from Jennifer Coller, Clinical Director of Cardiology at Goulburn Valley Health, and Mike Koroscik, Vice President of Allina Health Cancer Institute.

Jennifer Coller explores the trends in the healthcare landscape. Leveraging digital technology to enhance the patient experience is a crucial trend driven by patients’ increasing expectations. Mike Koroscik highlights the benefits of cell therapy as an emerging cancer treatment. Cellular immunotherapy, including CAR-T therapy, is reshaping cancer treatment, showing curative potential. This edition features other stories from IV therapy companies who provide valuable insights about innovative solutions shaping this space.

In this edition featuring the Top IV Therapy Services Providers in 2023, we hope you find the appropriate company suited to your business requirements.